Staar Surgical Co (STAA) Misses Q2 EPS by 2c

Staar Surgical Co (NASDAQ: STAA) reported Q2 adjusted EPS of $0.01, $0.02 worse than the analyst estimate of $0.03. Revenue for the quarter came in at $20.05 million versus the consensus estimate of $19.8 million.

2014 Annual Objectives

The Company's annual 2014 annual objectives were established at beginning of the year and the Company will continue to report progress each quarter on those objectives. Those annual objectives are:

• Revenue growth of 8% to 10%.
• ICL revenue growth of 20%.
• Gross Margin expansion of 300 bps, 72.7%.
• Profitable on a GAAP basis.
• Successfully complete manufacturing consolidation project by mid-year.

For earnings history and earnings-related data on Staar Surgical Co (STAA) click here.

You May Also Be Interested In

• Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
• Assurant (AIZ) is Piper Sandler's Weekly Focus Idea
• Notice to Long-Term Shareholders of Badger Meter, Inc. (NYSE: BMI); GeneDx Holdings Corp. (NASDAQ: WGS); GRAIL, Inc. (NASDAQ: GRAL); and Verra Mobility Corporation (NASDAQ: VRRM): Grabar Law Office i